Facing the COVID-19 outbreak: What should we know and what could we do?

J Med Virol. 2020 Jun;92(6):536-537. doi: 10.1002/jmv.25720. Epub 2020 Mar 5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus / genetics*
  • Betacoronavirus / pathogenicity
  • COVID-19
  • China / epidemiology
  • Communicable Disease Control / organization & administration*
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / transmission
  • Coronavirus Infections / virology
  • Humans
  • Pandemics* / prevention & control
  • Peptidyl-Dipeptidase A / genetics
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / prevention & control
  • Pneumonia, Viral / transmission
  • Pneumonia, Viral / virology
  • Protein Binding
  • Receptors, Virus / genetics
  • Receptors, Virus / metabolism
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / epidemiology*
  • Severe Acute Respiratory Syndrome / prevention & control
  • Severe Acute Respiratory Syndrome / transmission
  • Severe Acute Respiratory Syndrome / virology
  • Severe acute respiratory syndrome-related coronavirus / genetics*
  • Severe acute respiratory syndrome-related coronavirus / pathogenicity
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / metabolism

Substances

  • Receptors, Virus
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2